Semaglutide will not be prescribed to anyone with the following: BMI under 27, eating disorder, gallbladder disease, drug or alcohol abuse, recent bariatric surgery, pancreatitis, medullary thyroid cancer, currently pregnant or breastfeeding, planning to become pregnant, Diabetic retinopathy, Multiple endocrine neoplasia type 2, family history of medullary thyroid carcinoma.

• Service offered: Weight loss program
• Choose to opt for the Semaglutide Weight Loss Program (First Month) post-consultation

What to Expect:

• Package Components:
  • Consultation
  • The first dose of medication (if prescribed)
  • Prescription medication (if applicable)
  • Doctor-patient follow-up
  • Medications and materials needed for administration

Good to know:

• Semaglutide's weight loss program represents a promising and innovative approach to managing weight for individuals seeking effective solutions.
• Semaglutide, a medication originally developed for managing diabetes, has shown notable efficacy in supporting weight loss. The program involves the use of this medication, which acts as a glucagon-like peptide-1 (GLP-1) receptor agonist. By mimicking the effects of the natural hormone GLP-1, semaglutide helps regulate appetite and food intake, leading to a reduction in overall body weight.